Ebola virus antibody decay–stimulation in a high proportion of survivors

Neutralizing antibody function provides a foundation for the efficacy of vaccines and therapies(1–3). Here, using a robust in vitro Ebola virus (EBOV) pseudo-particle infection assay and a well-defined set of solid-phase assays, we describe a wide spectrum of antibody responses in a cohort of health...

Descripción completa

Detalles Bibliográficos
Autores principales: Adaken, Charlene, Scott, Janet T., Sharma, Raman, Gopal, Robin, Dicks, Steven, Niazi, Saidia, Ijaz, Samreen, Edwards, Tansy, Smith, Catherine C., Cole, Christine P., Kamara, Philip, Kargbo, Osman, Doughty, Heidi A., van Griensven, Johan, Horby, Peter W., Gevao, Sahr M., Sahr, Foday, Dimelow, Richard J., Tedder, Richard S., Semple, Malcolm G., Paxton, William A., Pollakis, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839293/
https://www.ncbi.nlm.nih.gov/pubmed/33505020
http://dx.doi.org/10.1038/s41586-020-03146-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839293/
https://www.ncbi.nlm.nih.gov/pubmed/33505020
http://dx.doi.org/10.1038/s41586-020-03146-y

Ejemplares similares